Language selection

Search

Patent 1068586 Summary

Third-party information liability

Some of the information on this Web page has been provided by external sources. The Government of Canada is not responsible for the accuracy, reliability or currency of the information supplied by external sources. Users wishing to rely upon this information should consult directly with the source of the information. Content provided by external sources is not subject to official languages, privacy and accessibility requirements.

Claims and Abstract availability

Any discrepancies in the text and image of the Claims and Abstract are due to differing posting times. Text of the Claims and Abstract are posted:

  • At the time the application is open to public inspection;
  • At the time of issue of the patent (grant).
(12) Patent: (11) CA 1068586
(21) Application Number: 281158
(54) English Title: .alpha.-AMYLASE ASSAY UTILIZING MODIFIED STARCH AS THE SUBSTRATE
(54) French Title: DOSAGE DE L'ACTIVITE DE L'.alpha.-AMYLASE SUR UN SUBSTRAT D'AMIDON MODIFIE
Status: Expired
Bibliographic Data
(52) Canadian Patent Classification (CPC):
  • 150/15.2
  • 150/3.2
(51) International Patent Classification (IPC):
  • C09K 3/00 (2006.01)
  • C12Q 1/40 (2006.01)
  • G01N 33/48 (2006.01)
(72) Inventors :
  • HUANG, CHARLES Y. (Not Available)
(73) Owners :
  • ABBOTT LABORATORIES (United States of America)
(71) Applicants :
(74) Agent:
(74) Associate agent:
(45) Issued: 1979-12-25
(22) Filed Date:
Availability of licence: N/A
(25) Language of filing: English

Patent Cooperation Treaty (PCT): No

(30) Application Priority Data: None

Abstracts

English Abstract






Abstract of the Disclosure
A specific and sensitive method for the
determination of .alpha.-amylase activities in a sample is
disclosed. The method utilizes a partially modified starch
substrate which contains blockages to the action of exo-
carbohydrases but not to .alpha.-amylase, an endo-carbohydrase.
Cleavage of the modified substrate by .alpha.-amylase leads to
free nonreducing ends which can then be attacked by a
suitable exo-carbohydrase serving as the coupling enzyme.
The reaction sequence is as follows: Blocked starch
.alpha.-amylase unblocked starch phosphoglucomutase inorganic
phosphate glucose-1-phosphate phosphoglucomutase
glucose-6-phosphate glucose-6-phosphate dehydrogenase, NAD
NADH. The rate of increase of absorbance due to NADH
formation can be measured to determine the level of
.alpha.-amylase activity in a sample, particularly one of serum
or urine origin. The values obtained are useful in
clinical diagnosis.


Claims

Note: Claims are shown in the official language in which they were submitted.




The embodiments of the invention in which an exclusive
property or privilege is claimed are defined as follows:

1. A method of assaying for .alpha.-amylase in a sample
which comprises incubating said sample with a modified starch
substrate containing blocked nonreducing ends in the presence
of a suitable phosphorylase, phosphoglucomutase, and glucose-
6-phosphate dehydrogenase as the coupling enzymes for the
measurement of the liberated nonreducing ends due to the action
of .alpha.-amylase.

2. A method according to Claim 1 in which said
sample is a biological fluid.

3. A method according to Claim 1 wherein said
phosphorylase is selected from animal, plant or microbial
sources.

4. A method according to Claim 3 in which the
phosphorylase is in the a or b sub-form.

5. A method according to Claim 1 in which the
liberated nonreducing ends in the presence of phosphate are
converted to glucose-1-phosphate.

6. A method according to Claim 1 in which said
phosphoglucomutase is selected from animal, plant or
microbial sources.

- 8 -



7, A method according to Claim 1 in which the
glucose-6-phosphate which is formed is reacted in the presence
of nicotinamide adeninedinucleotide (NAD) or nicotinamide
adeninedinucleotide phosphate (NADP) and glucose-6-phosphate
dehydrogenase which are thereby converted to 6-phosphogluconate
and reduced nicotinamide adeninedinucleotide (NADH) or reduced
nicotinamide adeninedinucleotide phosphate (NADPH), respectively.

8. A method according to Claim 7 in which said
glucose-6-phosphate dehydrogenase is selected from yeast or
leuconostoc sources,

9. A method according to Claim 7 in which the
formed reduced nicotinamide adeninedinucleotide or reduced
nicotinamide adeninedinucleotide is coupled to a suitable dye
in the presence of a suitable electron transfer agent.

10. A method according to Claim 9 in which said
dye is 2-p-iodophenyl-3-p-nitrophenyl-5-phenyl tetrazolium
chloride.

11. A method according to Claim 9 in which the
electron transfer agent is an enzyme selected from the group
consisting of diaphorase or phenazine methosulfate.

- 9 -




12. A method according to Claim 1 in which the
blocked substrate is selected from the group consisting of
branched or nonbranched polysaccharide.

13. A method according to Claim 12 in which the
substrate is a modified branched chain polysaccharide.

14. A reagent for use in assaying for .alpha.-amylase in
a sample comprising, in association:

Image

- 10 -



15. A reagent according to Claim 14 in which the
activator is adenosine 5'-monophosphate or an analog thereof.

16. A reagent according to Claim 14 in the form of
a dry, single solid.

17. A reagent according to Claim 16 in which the
dry reagent is made ready for use by the addition of water or
other suitable liquid.

18. A method according to Claim 13 in which the
polysaccharide may be modified to the extent of 2-10%,

19. A method according to Claim 2 wherein said
sample is serum.

- 11 -

Description

Note: Descriptions are shown in the official language in which they were submitted.


~068586
Back~round Of The Invention

a-Amylase levels in samples can be of considerable
importance, particularly in biological fluids such as serum
or urine. High levels of serum a-amylase usually signify
disorder of the pancreas. a-amylase hydrolyzes the ~ 4
;~ glucan linkages of polysaccharides and oligosaccharides in
a random fashion. The final produc~s are mainly maltose and
some glucose. Limit dextrins are also produced when branch-
chained starch is the substrate. Currently, a-amylase activity
is measured by one of the following methods: 1) Decrease in
viscosity of the starch solution; 2) Decrease in the ~-
turbidity of starch suspension; 3) Decrease in the intensity
of the starch-iodine complex; 4) Increase in the amount of
reducing ends (saccharogenic assay); 5) Formation of glucose
in a-glucosidase-coupled reaction; or 6) Intensity of chromagen
; in solution after cleavage of stained insoluble starch.
All of these current methods have one or several of
; the following disadvantages: Poor sensitivity; Long lag time;
Insoluble substrate; High background reading, especially when
glucose is present; Multi-step procedure; or Short linearity.
.'' .
I Summary Of The Invention

. .
-1 The method described herein concerns an assay for
the enzyme a-amylase (a-1,4-glucan-4-glucanohydrolase, EC
3.2.1.1) especially that of serum or urine origin, and has

-- 1 --
.~,
,~ ~

`'

~068586

particular application in clinical diagnosis. The method -
involves 1) the use of a modified starch which contains
~lockages to the action of the exo-acting enzymes (Marshall, J.J.
and Whelan, W.J., 1971, Anal. Biochem., 43, 316-321; Marshall,
J.J., 1970, Anal. Biochem., 2, 132-145) such as phosphorylase
and 2) the coupling of the reaction to a polysaccharide
phosphorylase so that glucose-l-phosphate is formed when ~-
.. ~
a-amylase is present. Phosphorylase attacks the starch from ;~
the nonreducing ends. Thus it cannot utilize the modified
10 starch (with blocked nonreducing ends) as a substrate. ~-
a-Amylase, on the other hand, is an endo-acting enzyme which
hydrolyzes the internal a-l--~ 4 bonds of the starch. Therefore,
the modified starch can serve as a substrate for a-amylase. The
hydrolytic action of a-amylase results in the revealing of
nonreducing ends which can then be utilized by phosphorylase
to form glucose-l-phosphate. The overall reaction sequence is
as follows:
Modified (blocked) starch a-amylase ~ Nonreducing ends
(unblocked starch)
Nonreducing ends inorganic phosphate (Pi) phosphorylase b
plus adenosine 5'-monophosphate (AMP) ~ or phosphorylase ~ -
= ~ or maltodextrin phosphorylase ~ glucose-l-phosphate
Glucose-l-phosphate phospho~lucomutase > glucose-6-phosphate
Glucose-6-phosphate nicotinamide adeninedinucleotide (NAD~,
glucose-6-phosphate dehydro~enase, ~r reduced nicotinamide
adeninedinucleotide plus 6-phosphogluconate. `


... .

;' .


. .

1 068586

; The rate of increase of absorbance at 340 nm. due to NADH
formation can be followed by a photometer to monitor the
enzymatic activity of a-amylase. With the addition of a
tetrazolium dye, 2-p-iodophenyl-3-nitrophenyl-5-phenyl
tetrazolium chloride (INT) and an electron carrier, the assay
~ can be converted into a colorimetric one: ~ -
; INT plus NADH diaphorase or phenazine methosulfate INTH
(Absorbance peak = 500 nm.) plus NAD. --
Compared with current methods, the method described
herein has the following advantages:
1) Since the reaction is coupled through the
formation of glucose-l-phosphate and glucose-
6-phosphate, which are not present at
appreciable levels in body flulds, the assay
is free from lnterference by glucose and other
reducing sugars. Consequently, a sample blank -
l, need not be performed.q 2) The coupling enzymes used in the reaction,
, namely, phosphorylase, phosphoglucomutase, and
glucose-6-phosphate dehydrogenase, all have
high activity at pH 7, the optimal pH for
a-amylase. Hence the assay can be performed
~') under the optimal reaction conditions. In
... .
~ other methods where the reaction is coupled
j
to a-glucosidase or glucoamylase, either a
;




lower pH or a large amount of the coupling
enzyme is required.
- 3 -




.
. .

~ . :

068586
~.
3) Each bond hydrolyzed by a-amylase immediately
results in the formation of glucose-l-phosphate.
Therefore, this reaction has little or no lag -
time. The a-glucosidase-coupled reaction has
a long lag time since a build-up of maltose is `
necessary prior to detection.
4) The activity of a-amylase can be measured in
a slngle operation in a continuous manner.
Other tests which utilize iodometric, visco-

metric, saccharogenis principles or dyed
substrates require separate steps. ` `
5) The assay offers high sensitivity and long
linearity. The viscometric, turbidimetric, ~-
and dyed-substrate approaches suffer from --
; either low sensitivity or short linearity ~ -~
~with respect to both the amount of a-amylase
and time).
In one particular a3pect the present invention provides
. .
a method of assaying for a-amylase in a sample which comprises ``
incubating said sample with a modified starch substrate con-
taining blocked nonreducing ends in the presence of a suitable
- phosphorylase, phosphoglucomutase, and glucose-6-phosphate
dehydrogenase as the coupling enzymes for the measurement of ~he
liberated nonreducing ends due to the action of a-amylase.
In another particular aspect the present invention provides
a reagent for use in assaying for a-amylase in a sample com-
prising, in association:

phosphate buffer,
i pH range of 6-8 20-100 mmoles/liter


Mg salts 1-5 mmoles/liter
adenosine 5'-mono-
phosphate 0.1-0.5 mmoles/liter
'' , ~ `'

jl/ ~ -4-

R'' : '
. ''`~

~068586
~ nicotinamide
adeninedinu-
cleotide 1-5 mmoles/liter

glucose-l,
6-diphosphate 0.1-5 U/mmoles/liter
NaCl 2-100 mmoles/liter

4% periodate .
oxidized, NaBHb
reduced starch 2-5 g/liter reagent

Phosphorylase b
(rabbit muscle) 8-30 U/ml reagent
Phosphoglucomutase 1-10 Utml reagent

Glucose-6-phosphate
dehydrogenase 5-50 U/ml reagent
Detailed Description of the Invention .
The preferred .substrate is a modified branch-chained : ;
polysaccharide, preferably modified to the extent of 2-10%.
The substrate used in the following description is a modified
amylopectin which is prepared by limited oxidation with
NaI04, followed by reduction by NaBH4, then by treatment with
- an exo-acting enzyme such as gluco-amylase, ~-amylase, or
phosphorylase to remove the unreacted nonreducing ends.


. .
' :

.,
, 20

. . .
.: - .

,':




`'
.
~ ` -4a-

- ` 10685~6 ~ ~ ~


: However, other methods of modification can be -
used. Starch glycollate and modified glycogen, amylose or
soluble starch, for instance, can serve as substrates in
; this reaction, though they are not as desirable. :.
The extent of oxidation also affects the efficiency
of the substrate. The substrate employed herein is 4%
oxidized amylopectin, but starches modified by lower or higher
percentage of oxidation (2-8%) have been shown to be good
substrates.
A single reagent, containing all of the ingredients .
for the determination of a-amylase, is represented by the
following formula:
- .
In~redient Concentration .
::~ Phosphate buffer, :: -
:~ 15 pH 7.0 20-100 mmoles/liter :
MgC12 1-5 mmoles/liter :
. AMP 0.1-0.5 mmoles/liter .
.; NAD 1-5 mmoles/liter -
Glucose-l, 6-
.~ 20 diphosphate 0.1-5 umoles/liter
NaCl 2-100 mmoles/liter
4% oxidized,
reduced starch 2-5 g/liter reagent
Phosphosylase b 8-30 U/ml reagent
--. 25(rabbit muscle)
Phosphoglucomatase 1-10 U/ml reagent
Glucose-6-phosphate
. dehydrogenase 5-50 U/ml reagent
: Assay temperature = 37C
-

:
.
:

~ ~ `


~68586

It should be emphasized that phosphorylase a -
or phosphorylase from other mammalian organs or from plant
or microbial sources can be used to replace phosphosylase b.
Maltodextrin phosphosylase (Schwartz, M. and Hofnung, M.,
1967, European J. Biochem; ~ 132-145) can also be used. In
addition, a mixture of several phosphorylases can be
employed to achieve higher efficiency. An analog may be
used in place of AMP. In colorimetric assay the following
ingredients are added:

INT 0.4g/liter reagent
Diaphorase 0.5U/ml reagent
. .

Any electron acceptor such as PMS can be used to replace
diaphorase.
As described, the method involves the use of a
modified starch in conjunction with a phosphorylase as the
~- ,
key coupling enzyme to produce an ultraviolet (UV) or a
` colorimetric test. Changes in the type of the modified
starch or the source of phosphosylase used are considered to
be within the scope of the invention. The glucose-6-phosphate
dehydrogenase can be obtained from yeast, leuconostoc or
other sources. The electron transfer agent can be an enzyme
such as diaphorase, phenazine methosulfate or other suitable
electron carrier.
The body fluid to be assay for ~-amylase can be
a serum or a urine sample. When human serum is the sample,

- 6
:'

1068586

20 ul. of serum is added to 1.0 ml of the above described
assay mixture and the reaction is followed at 340 nanometers
(nm) (or 500 nm in the colorimetric test) for 5 minutes at
37 with a suitable spectrophotometer. The procedure has
been adapted to the Abbott Bichrometic Analyzer 100, using
the following settings:
~' . .

37 C.
340/380 filter (500/600 filter for -
colorimetric test)
5 minute cycle
FRR (First revolution
reading) mode
Rate-up
1:51 syringe plate (1:101 plate for
lS color test)
:
When the previously described assay mixture and
procedure are used, the test is linear to 0.3 absorbance
unit per minute at 340 nm, equivalent to 6000U a-amylase/
liter serum. This method correlates very well with the
established iodometric method of Street and Close (Street,
H.V., and Close, J.R., 1956, Clin. Chim. Acta., 1, 256).
One Street and Close unit is equivalent to about five
international units.

'~ ' :''

-:
..

Representative Drawing

Sorry, the representative drawing for patent document number 1068586 was not found.

Administrative Status

For a clearer understanding of the status of the application/patent presented on this page, the site Disclaimer , as well as the definitions for Patent , Administrative Status , Maintenance Fee  and Payment History  should be consulted.

Administrative Status

Title Date
Forecasted Issue Date 1979-12-25
(45) Issued 1979-12-25
Expired 1996-12-25

Abandonment History

There is no abandonment history.

Owners on Record

Note: Records showing the ownership history in alphabetical order.

Current Owners on Record
ABBOTT LABORATORIES
Past Owners on Record
None
Past Owners that do not appear in the "Owners on Record" listing will appear in other documentation within the application.
Documents

To view selected files, please enter reCAPTCHA code :



To view images, click a link in the Document Description column. To download the documents, select one or more checkboxes in the first column and then click the "Download Selected in PDF format (Zip Archive)" or the "Download Selected as Single PDF" button.

List of published and non-published patent-specific documents on the CPD .

If you have any difficulty accessing content, you can call the Client Service Centre at 1-866-997-1936 or send them an e-mail at CIPO Client Service Centre.


Document
Description 
Date
(yyyy-mm-dd) 
Number of pages   Size of Image (KB) 
Drawings 1994-05-03 1 6
Claims 1994-05-03 4 103
Abstract 1994-05-03 1 32
Cover Page 1994-05-03 1 19
Description 1994-05-03 8 275